1-20 of 41
Milan Radovich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3781: Kinase fusion landscape of pancreatic cancer

Shivani Jagannathan Murali, Bharath Kumar Karre, Cristina Ivan, Chao Sima, Asfetaw Abera, David Spetzler, Milan Radovich, Heather O'neill, Ravi Chakra Turaga
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 3781.
https://doi.org/10.1158/1538-7445.AM2025-3781
Published: 21 April 2025
View articletitled, Abstract 3781: Kinase fusion landscape of pancreatic cancer
Journal Articles

Abstract 1474: Recurrent PRKCI gene fusions represent a drug target in gastric cancer and esophageal junction cancer

Shivani Jagannathan Murali, Bharath Kumar Karre, Cristina Ivan, Chao Sima, Asfetaw Abera, David Spetzler, Milan Radovich, Heather O'neill, Ravi Chakra Turaga
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 1474.
https://doi.org/10.1158/1538-7445.AM2025-1474
Published: 21 April 2025
View articletitled, Abstract 1474: Recurrent PRKCI gene fusions represent a drug target in gastric cancer and esophageal junction cancer
Journal Articles

Abstract 674: Functional characterization of SMARCA4 genomic variants

Shivani Jagannathan Murali, Bharath Kumar karre, Cristina Ivan, Kelly Craven, Stephanie Williams, Shikha Mahajan, Asfetaw Abera, Chao Sima, David Spetzler, Milan Radovich, Heather O'neill, Ravi Chakra Turaga
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 674.
https://doi.org/10.1158/1538-7445.AM2025-674
Published: 21 April 2025
View articletitled, Abstract 674: Functional characterization of SMARCA4 genomic variants
Journal Articles

Abstract 7140: Non-synonymous mutations in the IFN-γ pathway are predictive of response to immune checkpoint inhibition in NSCLC

Alexander Azizi, Arvind Ravi, Marzia Capelletti, Nicholas Haradhvala, Natalie Vokes, Stephen-John Sammut, Steven Ressler, Milan Radovich, Justin Gainor, Gad Getz
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 7140.
https://doi.org/10.1158/1538-7445.AM2025-7140
Published: 21 April 2025
View articletitled, Abstract 7140: Non-synonymous mutations in the IFN-γ pathway are predictive of response to immune checkpoint inhibition in NSCLC
Journal Articles

Abstract 4761: The ERBB4 exon skipping isoform JMA-CYT2 is the dominant isoform of ERBB4 gene fusions

Shivani Jagannathan Murali, Bharath Kumar Karre, Cristina Ivan, Chao Sima, Asfetaw Abera, David Spetzler, Milan Radovich, Heather O'neill, Ravi Chakra Turaga
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 4761.
https://doi.org/10.1158/1538-7445.AM2025-4761
Published: 21 April 2025
View articletitled, Abstract 4761: The ERBB4 exon skipping isoform JMA-CYT2 is the dominant isoform of ERBB4 gene fusions
Journal Articles

Abstract PO4-24-02: Comprehensive Characterization of BCL2 Family Genes in Metaplastic Triple Negative Breast Cancer

Pooja Advani, Sachin Deshmukh, Sharon Wu, Jacob Andring, Joanne Xiu, Alex Farrell, Milan Radovich, George Sledge Jr, Dario Trapani, Evanthia Roussos Torres, Stephanie Graff, Asher Chanan-Khan
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO4-24-02.
https://doi.org/10.1158/1538-7445.SABCS23-PO4-24-02
Published: 02 May 2024
View articletitled, Abstract PO4-24-02: Comprehensive Characterization of BCL2 Family Genes in Metaplastic Triple Negative Breast Cancer
Journal Articles

Abstract 6875: PIM kinases alter the prostate tumor immune microenvironment

Amber N. Clements, Kai Sutterby, Sachin Kumar Deshmukh, Sharon Wu, Joanne Xiu, Alex Farrell, Milan Radovich, Chadi Nabhan, Elisabeth I. Heath, Rana R. McKay, Alejandro Recio-Boiles, Noel A. Warfel
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6875.
https://doi.org/10.1158/1538-7445.AM2024-6875
Published: 22 March 2024
View articletitled, Abstract 6875: PIM kinases alter the prostate tumor immune microenvironment
Journal Articles

Abstract 2300: AI enabled whole exome& transcriptome liquid biopsy addressing MCED, MRD, and therapy selection on a single platform

Jim Abraham, Valeriy Domenyuk, Maria Perdigones Borderias, Takayuki Yoshino, Elisabeth I. Heath, Emil Lou, Stephen Liu, John Marshall, Wafik S. El-Deiry, Anthony Shields, Martin Dietrich, Yoshiaki Nakamura, Takao Fujisawa, David D. Halbert, Dominic Sacchetti, Seth Stahl, Adam Stark, Sergey Klimov, Sourabh Antani, Chadi Nabhan, Jeffrey Swensen, George Poste, Matt Oberley, Milan Radovich, George W. Sledge, David Spetzler
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2300.
https://doi.org/10.1158/1538-7445.AM2024-2300
Published: 22 March 2024
View articletitled, Abstract 2300: AI enabled whole exome& transcriptome liquid biopsy addressing MCED, MRD, and therapy selection on a single platform
Journal Articles

Abstract 1895: Molecular characterization of prostate cancer between Hispanic American and Non-Hispanic Whites: Implications for cancer ethnic health disparities

Alejandro Recio-Boiles, Sachin Kumar Deshmukh, Juan Chipollini, Ken Batai, Sharon Wu, Joanne Xiu, Alex Farrell, Milan Radovich, Elisabeth Heath, Rana McKay, Chadi Nabhan
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1895.
https://doi.org/10.1158/1538-7445.AM2023-1895
Published: 04 April 2023
View articletitled, Abstract 1895: Molecular characterization of prostate cancer between Hispanic American and Non-Hispanic Whites: Implications for cancer ethnic health disparities
Journal Articles

Abstract PD9-10: BRE12-158: A post-neoadjuvant, randomized phase 2 trial of personalized therapy vs. treatment of physician’s choice for patients with residual triple negative breast cancer

Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger, Fei Shen, Christopher Chitambar, Rita Nanda, Carla Falkson, Filipa C Lynce, Christopher Gallagher, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Karen Daily, Reshma Mahtani, Michael A Thompson, Robert Graham, Maureen E Cooper, Dean C Pavlick, Lee A Albacker, Jeffery Gregg, Jeffery P Solzak, Yu-Hsiang Chen, Casey L Bales, Erica Cantor, Bradley A Hancock, Nawal Kassem, Paul Helft, Bert O'Neil, Anna Maria Storniolo, Sunil Badve, Kathy D Miller, Milan Radovich
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD9-10.
https://doi.org/10.1158/1538-7445.SABCS21-PD9-10
Published: 15 February 2022
View articletitled, Abstract PD9-10: BRE12-158: A post-neoadjuvant, randomized phase 2 trial of personalized therapy vs. treatment of physician’s choice for patients with residual triple negative breast cancer
Journal Articles

Abstract P4-01-07: Insights into the compensation mechanism behind targeting PI3K and Wnt in triple-negative breast cancer

Jeffrey P Solzak, Chao Wang, Milan Radovich
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P4-01-07.
https://doi.org/10.1158/1538-7445.SABCS21-P4-01-07
Published: 15 February 2022
View articletitled, Abstract P4-01-07: Insights into the compensation mechanism behind targeting PI3K and Wnt in triple-negative breast cancer
Journal Articles

Abstract PS10-26: An initial safety study of gedatolisib plus cofetuzumab pelidotin for metastatic triple-negative breast cancer

Milan Radovich, Jeffrey P. Solzak, Bradley A. Hancock, Sunil Badve, Anna Maria V. Storniolo, Tarah J. Ballinger, Bryan P. Schneider, Kathy D. Miller
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS10-26.
https://doi.org/10.1158/1538-7445.SABCS20-PS10-26
Published: 15 February 2021
View articletitled, Abstract PS10-26: An initial safety study of gedatolisib plus cofetuzumab pelidotin for metastatic triple-negative breast cancer
Journal Articles

Abstract PS11-14: Advanced precision health resources in the Susan G Komen tissue bank at the IU simon comprehensive cancer center

Steven M Bray, Swee Seong Wong, Baiju G Parikh, Kevin C Wood, Samuel T Rysdyk, Jill E Henry, Natascia Marino, Milan Radovich, Anna Maria V Storniolo
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS11-14.
https://doi.org/10.1158/1538-7445.SABCS20-PS11-14
Published: 15 February 2021
View articletitled, Abstract PS11-14: Advanced precision health resources in the Susan G Komen tissue bank at the IU simon comprehensive cancer center
Journal Articles

Abstract PD15-06: Circulating TP53 mutations in TNBC after neoadjuvant chemotherapy is associated with rapid disease recurrence: Correlative analysis from clinical trial BRE12-158

Milan Radovich, Nawal Kassem, Guanglong Jiang, Bradley A. Hancock, Bryan P. Schneider
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PD15-06.
https://doi.org/10.1158/1538-7445.SABCS20-PD15-06
Published: 15 February 2021
View articletitled, Abstract PD15-06: Circulating TP53 mutations in TNBC after neoadjuvant chemotherapy is associated with rapid disease recurrence: Correlative analysis from clinical trial BRE12-158
Journal Articles

Abstract 711: Co-detection of circulating tumor DNA and RNA for enhanced detection of minimal residual disease in patients with chemorefractory triple-negative breast cancer

Yu-Hsiang Chen, Bradley A. Hancock, Jeffrey P. Solzak, Bryan P. Schneider, Kathy D. Miller, Milan Radovich
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 711.
https://doi.org/10.1158/1538-7445.AM2020-711
Published: 15 August 2020
View articletitled, Abstract 711: Co-detection of circulating tumor DNA and RNA for enhanced detection of minimal residual disease in patients with chemorefractory triple-negative breast cancer
Journal Articles

Abstract GS5-02: Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy is significantly associated with disease recurrence in early-stage triple-negative breast cancer (TNBC): Preplanned correlative results from clinical trial BRE12-158

Milan Radovich, Guanglong Jiang, Christopher Chitambar, Rita Nanda, Carla Falkson, Filipa C. Lynce, Christopher Gallagher, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Karen Daily, Reshma Mahtani, Michael A. Thompson, Robert Graham, Maureen E. Cooper, Dean C. Pavlick, Lee Albacker, Jeff Gregg, Casey L. Bales, Bradley A. Hancock, Erica Cantor, Fei Shen, Anna Maria V. Storniolo, Sunil Badve, Tarah Ballinger, Kathy D. Miller, Bryan P. Schneider
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): GS5-02.
https://doi.org/10.1158/1538-7445.SABCS19-GS5-02
Published: 15 February 2020
View articletitled, Abstract GS5-02: Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy is significantly associated with disease recurrence in early-stage triple-negative breast cancer (TNBC): Preplanned correlative results from clinical trial BRE12-158
Journal Articles

Abstract P3-10-12: Targeting a common drug compensation pathway using NUPR1 inhibition in triple negative breast cancer

Jeffrey P Solzak, Chao Wang, Brad Hancock, Milan Radovich
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P3-10-12.
https://doi.org/10.1158/1538-7445.SABCS19-P3-10-12
Published: 15 February 2020
View articletitled, Abstract P3-10-12: Targeting a common drug compensation pathway using NUPR1 inhibition in triple negative breast cancer
Journal Articles

Abstract P4-01-16: 4-marker positive selection system for improved circulating tumor cell analysis of metastatic triple-negative breast cancer

Bradley A. Hancock, Yuan Zhong, Chun-Li Chang, Yu-Hsiang Chen, Jeffrey P. Solzak, Casey L. Bales, Emily M. Nelson, Cagri Savran, Milan Radovich
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P4-01-16.
https://doi.org/10.1158/1538-7445.SABCS19-P4-01-16
Published: 15 February 2020
View articletitled, Abstract P4-01-16: 4-marker positive selection system for improved circulating tumor cell analysis of metastatic triple-negative breast cancer
Journal Articles

Abstract LB-303: Transposable element insertions impact the mutational landscape of breast cancer genomes and disease onset

Robin Paul, Milan Radovich, Jeffrey P. Solzak
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): LB-303.
https://doi.org/10.1158/1538-7445.AM2019-LB-303
Published: 01 July 2019
View articletitled, Abstract LB-303: Transposable element insertions impact the mutational landscape of breast cancer genomes and disease onset
Journal Articles

Abstract 2066: Targeting NUPR1: Response to a common compensatory pathway in triple negative breast cancer

Jeffrey P. Solzak, Milan Radovich
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2066.
https://doi.org/10.1158/1538-7445.AM2019-2066
Published: 01 July 2019
View articletitled, Abstract 2066: Targeting NUPR1: Response to a common compensatory pathway in triple negative breast cancer